Senseera logo

Senseera

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$7.1M


Senseera is a liquid biopsy company that develops a platform for non-invasive disease detection and monitoring using chromatin epigenomics technology, with a focus on oncology, immunology, and metabolic diseases.

Total Funding

$7.1M

Headquarters

Jerusalem, Israel

Founded

N/A

Focus Areas

Liquid biopsy
chromatin epigenomics
non-invasive detection
oncology diagnostics
immunology
metabolic diseases

Investors